Mitsubishi UFJ Trust & Banking’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Sell
34,286
-1,849
-5% -$853K 0.04% 372
2026
Q1
$17.4M Sell
36,135
-9,998
-22% -$5.12M 0.04% 360
2025
Q4
$25.9M Sell
46,133
-9,728
-17% -$5.52M 0.06% 294
2025
Q3
$28.7M Buy
55,861
+7,194
+15% +$3.14M 0.06% 303
2025
Q2
$15.3M Buy
48,667
+12,829
+36% +$3.85M 0.04% 443
2025
Q1
$10.9M Sell
35,838
-2,792
-7% -$939K 0.03% 516
2024
Q4
$12.8M Buy
38,630
+11,099
+40% +$3.76M 0.03% 511
2024
Q3
$9.19M Buy
27,531
+7,571
+38% +$2.88M 0.02% 590
2024
Q2
$8.22M Buy
+19,960
New +$7.9M 0.02% 589

Other funds holding MEDP

Mitsubishi UFJ Trust & Banking's MEDP Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking reduced its Medpace (MEDP) stake by 5.1% in Q2 2026, selling an estimated $853K and leaving 34,286 shares worth $18.2M. The position accounts for 0.04% of the portfolio, ranked #372.

Mitsubishi UFJ Trust & Banking first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $28.7M in Q3 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 34,286 shares of Medpace worth $18.2M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking sold 1,849 Medpace shares in Q2 2026, an estimated $853K.
  • Medpace made up 0.04% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #372 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Mitsubishi UFJ Trust & Banking's Medpace position peaked at $28.7M in Q3 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.